P. Pappas

发表

Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

J. Cleary, W. Powderly, J. Rex, 2003, Antimicrobial Agents and Chemotherapy.

Antifungal combination therapy: clinical potential.

J. Baddley, P. Pappas, 2005, Drugs.

Prevention and treatment of cancer-related infections.

R. Garzon, S. Seo, J. Montoya, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

B. Alexander, J. Wingard, H. Tamura, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

International collaboration between US and Thailand on a clinical trial of treatment for HIV-associated cryptococcal meningitis.

P. Pappas, T. Nolen, P. Chetchotisakd, 2010, Contemporary clinical trials.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Patricia Muñoz, Angela Restrepo, Raoul Herbrecht, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of the Use of Administrative Data and an Active System for Surveillance of Invasive Aspergillosis

G. Lyon, K. Wannemuehler, S. Fridkin, 2008, Infection Control & Hospital Epidemiology.

Candidemia and Invasive Candidiasis.

P. Pappas, Todd P. McCarty, Cameron White, 2021, Infectious disease clinics of North America.

The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

G. Lyon, B. Alexander, J. Baddley, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Micafungin for candidiasis

P. Pappas, P. Pappas, 2012 .

Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases

P. Pappas, O. Cornely, A. Ullmann, 2011, Expert opinion on drug safety.

Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease

F. Marty, P. Pappas, O. Cornely, 2011, Mycoses (Berlin).

Candidemia in the intensive care unit: miles to go before we sleep.

P. Pappas, 2011, Critical care medicine.

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans : a multivariate analysis of factors associated with improved outcome

A. Shorr, P. Biswas, A. Reboli, 2016 .

CHAPTER 29 – Hematogenously disseminated fungal infections

S. Baer, P. Pappas, 2009 .

The patient with candidemia: Treatment choices and algorithms

P. Pappas, 2008 .

Invasive Fungal Pathogens: Current Epidemiological Trends

Peter G. Pappas, J. Wingard, M. Pfaller, 2006 .

A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

M. Levenstein, J. Rex, J. Bennett, 1994 .

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

J. Sobel, S. Filler, J. Rex, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phase I Evaluation of the Safety and Pharmacokinetics of Murine-Derived Anticryptococcal Antibody 18B7 in Subjects with Treated Cryptococcal Meningitis

A. Casadevall, J. Perfect, J. Aberg, 2005, Antimicrobial Agents and Chemotherapy.

Fungal infections associated with contaminated methylprednisolone injections.

T. Patterson, P. Pappas, C. Kauffman, 2013, The New England journal of medicine.

Epidemiology of Aspergillus terreus at a University Hospital

J. Baddley, S. Moser, P. Pappas, 2003, Journal of Clinical Microbiology.

Molecular Identification of Aspergillus Species Collected for the Transplant-Associated Infection Surveillance Network

B. Alexander, J. Baddley, D. Kontoyiannis, 2009, Journal of Clinical Microbiology.

Itraconazole for the treatment of histoplasmosis and blastomycosis.

P. Pappas, J. Mangino, 1995, International journal of antimicrobial agents.

Surveillance of cryptococcosis in Alabama, 1992-1994.

R. Pinner, M. Bradley, P. Pappas, 1998, Annals of epidemiology.

Safety, Tolerance, and Pharmacokinetics of High-Dose Liposomal Amphotericin B (AmBisome) in Patients Infected withAspergillus Species and Other Filamentous Fungi: Maximum Tolerated Dose Study

E. Anaissie, T. Walsh, I. Bekersky, 2001, Antimicrobial Agents and Chemotherapy.

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

J. Perfect, V. Morrison, D. Stevens, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis.

J. Perfect, D. Denning, J. Galgiani, 1994, The American journal of medicine.

Factors associated with mortality in transplant patients with invasive aspergillosis.

E. Anaissie, O. Williams, B. Alexander, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Penile intraepithelial neoplasia: clinical presentation and an analysis of the physical state of human papillomavirus DNA.

M. Stoler, L. Corey, L. Demeter, 1993, The Journal of infectious diseases.

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

M. Ghannoum, M. Castanheira, S. Lockhart, 2012, Journal of Clinical Microbiology.

Anidulafungin versus fluconazole for invasive candidiasis.

R. Betts, Deepali Kumar, A. Reboli, 2007, The New England journal of medicine.

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

B. Alexander, J. Sobel, V. Morrison, 2007, European Journal of Clinical Microbiology & Infectious Diseases.

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.

J. Rex, J. Bennett, J. Edwards, 1994, The New England journal of medicine.

Invasive candidiasis in the intensive care unit

L. Ostrosky-Zeichner, P. Pappas, 2006, Critical care medicine.

Invasive Non-Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006

G. Papanicolaou, E. Anaissie, G. Lyon, 2011, Emerging infectious diseases.

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

J. Sobel, J. Vazquez, A. Reboli, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunotherapy for invasive fungal infections: from bench to bedside.

P. Pappas, 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Intravascular Catheter Exchange and Duration of Candidemia

J. Serody, J. Rex, J. Bennett, 1995 .

Prevention of Firearm Violence Through Specific Types of Community-based Programming

J. Como, R. Rattan, M. Crandall, 2021, Annals of surgery.

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

J. Sobel, J. Baddley, B. Kullberg, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Combination Antifungal Therapy for Invasive Aspergillosis

J. Wingard, F. Queiroz-Telles, D. Kontoyiannis, 2015, Annals of Internal Medicine.

Cryptococcal antigen in serum and cerebrospinal fluid for detecting cryptococcal meningitis in adults living with HIV: systematic review and meta-analysis of diagnostic test accuracy studies.

Jérémie F. Cohen, J. Perfect, T. Harrison, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19

M. Hoenigl, T. Patterson, C. Clancy, 2020, Open forum infectious diseases.

Immunosuppression Regimen and the Risk of Acute Rejection in HIV-Infected Kidney Transplant Recipients

D. Segev, R. Montgomery, J. Baddley, 2014, Transplantation.

Viral latency--the papillomavirus model.

S. Vermund, T. R. Broker, L. Chow, 2001, Developments in biologicals.

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

J. Perfect, H. Masur, A. Caliendo, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis.

S. Filler, W. Manosuthi, P. Pappas, 2009, International journal of antimicrobial agents.

Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).

E. Anaissie, G. Lyon, K. Wannemuehler, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospital.

J. Baddley, S. Moser, P. Pappas, 2001, Diagnostic microbiology and infectious disease.

Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing

J. Wingard, J. Löffler, P. White, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fungal infections in ventricular assist devices.

J. Baddley, S. Goldberg, P. Pappas, 2000, ASAIO journal.

Immune Reconstitution Inflammatory Syndrome after Antiretroviral Therapy in AIDS Patients with Cryptococcal Meningitis : A Prospective Multicenter Study

J. Sobel, S. Filler, A. Kendrick, 2009 .

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.

J. Sobel, S. Filler, A. Kendrick, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acyclovir with and without Prednisone for the Treatment of Herpes Zoster

F. Hayden, S. Soong, S. Tyring, 1996, Annals of Internal Medicine.

Cryptococcal Infections: Changing Epidemiology and Implications for Therapy

P. Pappas, R. L. La Hoz, P. Pappas, 2013, Drugs.

Reply to Mafaciolli and Pasqualotto

J. Donnelly, J. Maertens, P. Verweij, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium.

J. Perfect, Melissa D. Johnson, D. Kontoyiannis, 2020, The Journal of infectious diseases.

Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitis a

S. Tansuphaswadikul, W. Manosuthi, P. Pappas, 2008, International journal of STD & AIDS.

Epidemiology of Invasive Mold Infections in Lung Transplant Recipients

B. Alexander, J. Baddley, Benjamin J Park, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group.

A. Schuchat, L. Hutwagner, R. Pinner, 1999, The Journal of infectious diseases.

Erratum: NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis (American Journal of Medicine (August 1994) 97 (135-144))

J. Perfect, D. Denning, J. Galgiani, 1994 .

The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis

Christina A. Cuomo, A. Casadevall, J. Perfect, 2017, mSphere.

Antifungal Trials: Progress, Approaches, New Targets, and Perspectives in Cryptococcosis

P. Pappas, 2011 .

Improvement of Gram-negative Susceptibility to Fluoroquinolones After Implementation of a Pre-Authorization Policy for Fluoroquinolone Use: A Decade-Long Experience

R. Griffin, S. Moser, P. Pappas, 2017, Infection Control & Hospital Epidemiology.

Race and invasive fungal infection in solid organ transplant recipients.

G. Mcgwin, G. Lyon, J. Baddley, 2014, Ethnicity & disease.

Comparison of In Vitro Susceptibility Characteristics of Candida Species from Cases of Invasive Candidiasis in Solid Organ and Stem Cell Transplant Recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006

J. Baddley, S. Lockhart, J. Ito, 2011, Journal of Clinical Microbiology.

Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.

G. Lyon, M. Boeckh, J. Baddley, 2013, Medical mycology.

Cryptococcal infections in non-HIV-infected patients.

P. Pappas, 2013, Transactions of the American Clinical and Climatological Association.

Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)‐infected and HIV‐uninfected persons

J. Baddley, L. Miller, S. Moser, 2012, Transplant infectious disease : an official journal of the Transplantation Society.

The role of azoles in the treatment of invasive mycoses: review of the Infectious Diseases Society of America guidelines

P. Pappas, 2011 .

In Vitro Echinocandin Susceptibility of Aspergillus Isolates from Patients Enrolled in the Transplant-Associated Infection Surveillance Network

J. Baddley, S. Lockhart, J. Ito, 2011, Antimicrobial Agents and Chemotherapy.

In vitro susceptibility of Aspergillus to echinocandins: Isolates from patients enrolled in the

J. Baddley, S. Lockhart, T. Chiller, 2011 .

Fungal Infections in Solid Organ Transplant Recipients

P. Pappas, 2011 .

Patty W. Wright, D. Pappagianis, S. Moser, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons.

D. Bamberger, G. Cloud, R. Hajjeh, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.

R. M. Warren, J. Perfect, D. Haas, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis.

W. Powderly, J. Vazquez, P. Pappas, 2019, The Journal of antimicrobial chemotherapy.

Surgical treatment of multiple skull abscesses associated with coccidioidomycosis

C. Cobbs, J. Baddley, P. Pappas, 2004, Mycoses.

Principles of Antifungal Therapy

P. Pappas, 2010 .

Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry.

P. Pappas, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups.

J. Powers, J. Galgiani, C. Viscoli, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group.

G. Campbell, G. Cloud, W. Dismukes, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fluconazole Therapy for Histoplasmosis

G. Cloud, W. Dismukes, P. Pappas, 1996 .

Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole.

J. Perfect, G. Cloud, W. Dismukes, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of blastomycosis with fluconazole: a pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group.

G. Cloud, W. Dismukes, P. Pappas, 1995, Clinical Infectious Diseases.

Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial

Á. Soriano, M. Bassetti, J. Vazquez, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antifungal clinical trials and guidelines: what we know and do not know.

P. Pappas, 2014, Cold Spring Harbor perspectives in medicine.

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

P. Biswas, J. Vazquez, A. Reboli, 2014, BMC Infectious Diseases.

Ocular manifestations of candidemia.

J. Sobel, C. Viscoli, A. Rothova, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Candida infective endocarditis

V. Fowler, D. Levine, J. Baddley, 2008, European Journal of Clinical Microbiology & Infectious Diseases.

Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.

J. Serody, J. Rex, J. Bennett, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida species.

R. Wenzel, J. Galgiani, H. Gallis, 1994, Diagnostic microbiology and infectious disease.

The Evolving Epidemiology of Sporotrichosis

P. Pappas, T. McCarty, 2014, Current Fungal Infection Reports.

Therapeutic approach to Candida sepsis

J. Rex, P. Pappas, 1999, Current infectious disease reports.

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel

A. Caliendo, G. Lyon, K. Garey, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit

J. Sobel, A. Reboli, S. Shoham, 2011, Mycoses.

MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.

A. Westfall, R. Betts, J. Caeiro, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reply to Kontoyiannis

J. Sobel, T. Calandra, B. Kullberg, 2009 .

Invasive mold infections in allogeneic bone marrow transplant recipients.

J. Baddley, P. Pappas, D. Salzman, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Design and Methodology of the Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR-ICU) Trial

M. Samore, D. Goldmann, W. Huskins, 2007, Infection Control & Hospital Epidemiology.

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

J. Perfect, G. Rahav, F. Marty, 2016, The Lancet. Infectious diseases.

MSG07: An International Cohort Study Comparing Epidemiology and Outcomes of Patients with Cryptococcus neoformans or Cryptococcus gattii infections.

B. Jackson, J. Perfect, T. Sorrell, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A paradoxical decline: intracranial lesions in two HIV-positive patients recovering from cryptococcal meningitis

P. Pappas, P. Chin-Hong, Sanjiv M. Baxi, 2015, BMJ Case Reports.

Update on Multistate Outbreak of Fungal Infections Associated with Contaminated Methylprednisolone Injections, 2012-2014.

O. Mccotter, T. Chiller, R. Mody, 2015, MMWR. Morbidity and mortality weekly report.

Activity of posaconazole in the treatment of central nervous system fungal infections.

P. Pitisuttithum, J. Graybill, R. Negroni, 2005, The Journal of antimicrobial chemotherapy.

Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis.

J. Powers, J. Galgiani, C. Viscoli, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.

J. Powers, J. Galgiani, C. Viscoli, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acute Cryptococcal Immune Reconstitution Inflammatory Syndrome in a Patient on Natalizumab

J. Drwiega, P. Pappas, S. Jordan, 2016, Open forum infectious diseases.

Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.

J. Sobel, G. Rahav, C. Viscoli, 2018, Clinical Infectious Diseases.

Comparison between liposomal formulations of amphotericin B.

J. Adler-Moore, P. Pappas, J. Gangneux, 2016, Medical mycology.

Combination antifungal therapy for the treatment of invasive yeast and mold infections

J. Baddley, P. Pappas, 2007, Current infectious disease reports.

Invasive candidiasis.

P. Pappas, 2006, Infectious disease clinics of North America.

Recombinant Interferon-γlb as Adjunctive Therapy for AIDS-Related Acute Cryptococcal Meningitis

E. Ticona, J. Aberg, A. Reboli, 2004 .

Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.

E. Ticona, J. Aberg, A. Reboli, 2004, The Journal of infectious diseases.

Long-term Outcomes of Patients With Fungal Infections Associated With Contaminated Methylprednisolone Injections

Patty W. Wright, Brendan R. Jackson, Patricia F Triplett, 2020, Open forum infectious diseases.

Lessons learned in the multistate fungal infection outbreak in the United States.

P. Pappas, 2013, Current opinion in infectious diseases.

Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for FKS-Associated Echinocandin Resistance in Candida glabrata Septic Arthritis and Osteomyelitis

K. Marr, P. Pappas, R. Shields, 2019, Antimicrobial Agents and Chemotherapy.

Blastomycosis in patients with the acquired immunodeficiency syndrome.

R. Shafer, C. Stratton, V. Fraser, 1992, Annals of internal medicine.

Cytomegalovirus appendicitis in solid organ transplant patients, two cases and a review.

P. Pappas, R. Lee, T. McCarty, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Superficial and Mucosal Fungal Infections

P. Pappas, B. Bergamo, 2007 .

Cerebral Infarction From Acquired Immunodeficiency Syndrome-Related Cryptococcal Meningitis: An Overlooked Complication of a Common Opportunistic Infection?

S. Geraci, P. Pappas, S. Chapman, 2010 .

Laboratory in the diagnosis and management of urinary tract infections.

P. Pappas, 1991, The Medical clinics of North America.

Reply to Bauer and Goff.

K. Garey, E. Mylonakis, G. Alangaden, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Kawasaki syndrome clusters in Harris County, Texas, and eastern North Carolina. A high endemic rate and a new environmental risk factor.

L. Schonberger, S. Kaplan, P. Pappas, 1988, American journal of diseases of children.

Reply to Dr. Chandrasekar (Clin Infect Dis 2001; 32:320-1) and Drs. Marr and Boeckh (Clin Infect Dis 2001; 32:321).

J. Sobel, S. Filler, J. Rex, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk factors for acquisition of endemic blastomycosis.

E. Trepman, B. Light, M. Cheang, 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Predictors of Mortality and Differences in Clinical Features among Patients with Cryptococcosis According to Immune Status

J. Baddley, P. Pappas, K. Brizendine, 2013, PloS one.

Current concepts in the management of fungal peritonitis

P. Pappas, Michelle R. Salvaggio, 2003, Current infectious disease reports.

A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis.

J. Sobel, S. Filler, A. Kendrick, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America.

M. Threlkeld, W. Dismukes, P. Pappas, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

J. Sobel, T. Calandra, D. Benjamin, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

R. Betts, J. D. De Waele, B. Suh, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Guidelines for treatment of candidiasis.

J. Sobel, S. Filler, J. Rex, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

J. Sobel, S. Filler, J. Rex, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

J. Perfect, S. Holland, J. Sobel, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CHAPTER 60 – Systemic fungal infections

P. Pappas, P. Seal, 2010 .

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

K. Wannemuehler, B. Marston, Benjamin J Park, 2009, AIDS.

Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America.

P. Pappas, C. Kauffman, S. Chapman, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day−1) in the treatment of cutaneous or lymphocutaneous sporotrichosis

S. Emady-Azar, R. Dietze, Á. Restrepo, 2004, Mycoses.

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.

K. Wannemuehler, S. Fridkin, D. Kontoyiannis, 2005, Medical mycology.

Prevention and Treatment of Cancer-Related InfectionsPractice Guidelines in Oncology

R. Garzon, S. Seo, J. Montoya, 2012 .

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

J. Perfect, M. Saag, J. Sobel, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases

B. Alexander, J. Baddley, C. Seas, 2017, Open forum infectious diseases.

Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET).

G. Lyon, B. Alexander, J. Baddley, 2015, Medical mycology.

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

J. Perfect, Nina Singh, J. Sobel, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Alopecia Associated with Fluconazole Therapy

J. Perfect, J. Sobel, D. Bamberger, 1995, Annals of Internal Medicine.

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.

E. Anaissie, J. Perfect, J. Wingard, 2002, The New England journal of medicine.

Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

R. Finberg, C. Arndt, T. Walsh, 1999 .

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

R. Finberg, C. Arndt, T. Walsh, 1999, The New England journal of medicine.

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

J. Sobel, A. Reboli, T. Walsh, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Microascus cinereus (AnamorphScopulariopsis) Brain Abscess in a Bone Marrow Transplant Recipient

J. Baddley, S. Moser, D. Sutton, 2000, Journal of Clinical Microbiology.

Microascus cinereus (Anamorph scopulariopsis) brain abscess in a bone marrow transplant recipient.

J. Baddley, S. Moser, D. Sutton, 2000, Journal of clinical microbiology.

Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.

M. Saag, K. Squires, D. Bamberger, 1997, The American journal of medicine.

Fungal Infections Associated with Contaminated Methylprednisolone Injections — Preliminary Report

T. Patterson, P. Pappas, C. Kauffman, 2013 .

Blastomycosis in the immunocompromised patient.

P. Pappas, Peter G. Pappas, 1997, Seminars in respiratory infections.

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

J. Sobel, J. Cleary, D. Cohen, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intraocular blastomycosis: case report and review.

P. Pappas, J. Mason, J. Parker, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Blastomycosis: new insights into diagnosis, prevention, and treatment.

P. Pappas, J. McKinnell, 2009, Clinics in chest medicine.

Sporotrichosis in Peru: description of an area of hyperendemicity.

P. Pappas, I. Téllez, B. Bustamante, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era.

Patty W. Wright, P. Pappas, L. Proia, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial

E. Mylonakis, C. Clancy, M. Nguyen, 2018, Journal of Clinical Microbiology.

T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.

K. Garey, E. Mylonakis, G. Alangaden, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV‐associated cryptococcal meningitis‐infected patients

S. Filler, D. Andes, W. Manosuthi, 2010, HIV medicine.

Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya

J. Baddley, I. Aban, W. Jaoko, 2011, Mycoses.

Cryptococcal Meningitis: Current Approaches to Management in Patients With and Without AIDS

P. Pappas, K. Brizendine, 2010, Current infectious disease reports.

Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America.

G. Campbell, P. Pappas, C. Kauffman, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Real-Time Treatment Guidelines: Considerations during the Exserohilum rostratum Outbreak in the United States

J. Perfect, D. Kontoyiannis, T. Chiller, 2013, Antimicrobial Agents and Chemotherapy.

The prevalence, clinical features, risk factors and outcome associated with cryptococcal meningitis in HIV positive patients in Kenya.

J. Baddley, I. Aban, W. Jaoko, 2010, East African medical journal.

Essentials of clinical mycology

J. Sobel, W. Dismukes, P. Pappas, 2011 .

Invasive Candidiasis.

B. Kullberg, M. Arendrup, M. Lionakis, 2019, The New England journal of medicine.

Vertebral blastomycosis with paravertebral abscess: report of eight cases and review of the literature.

P. Pappas, M. Saccente, R. Abernathy, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

W. Powderly, J. Rex, J. Edwards, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network

J. Baddley, J. Ito, D. Kontoyiannis, 2009, Journal of Clinical Microbiology.

JCM00854-09 REVISION 1 Susceptibility Patterns of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant Associated Infection Surveillance Network (TRANSNET)

J. Baddley, J. Ito, D. Kontoyiannis, 2009 .

Nonsporulating Clinical Isolate Identified as Petromyces alliaceus (Anamorph Aspergillus alliaceus) by Morphological and Sequence-Based Methods

J. Ito, S. Balajee, M. Brandt, 2007, Journal of Clinical Microbiology.

Factors Associated With Ventriculoperitoneal Shunt Placement in Patients With Cryptococcal Meningitis

J. Baddley, S. Moser, K. Riley, 2019, Open forum infectious diseases.

Yeast Infections After Solid Organ Transplantation

P. Pappas, T. McCarty, T. Mccarty, 2016 .

Managing cryptococcal meningitis is about handling the pressure.

P. Pappas, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Therapy of cryptococcal meningitis in non-HIV-infected patients

P. Pappas, 2001, Current infectious disease reports.

A Multicenter, Longitudinal Cohort Study of Cryptococcosis in HIV-Negative People in the United States.

P. Williamson, Sean X. Zhang, K. Marr, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

MORTALITY AFTER CLINICAL MANAGEMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS IN KENYA.

J. Baddley, I. Aban, W. Jaoko, 2014, East African medical journal.

Detection of specific antibodies in human blastomycosis by enzyme immunoassay.

P. Pappas, R. Bradsher, 1995, Southern medical journal.

Histoplasmosis: Time to Redraw the Map and Up Our Game.

P. Pappas, D. McKinsey, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fluconazole therapy for histoplasmosis. The National Institute of Allergy and Infectious Diseases Mycoses Study Group.

G. Cloud, W. Dismukes, P. Pappas, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease

A. Zaas, J. Perfect, D. Haas, 2008, European Journal of Clinical Microbiology & Infectious Diseases.

Infections in the neutropenic patient--new views of an old problem.

D. Maki, C. Crnich, K. Rolston, 2001, Hematology. American Society of Hematology. Education Program.

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

Thomas J Walsh, Randall Walker, Kieren A Marr, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

1718. Rezafungin Clinical Safety and Efficacy in Patients With Candidemia and/or Invasive Candidiasis in the Randomized, Double-Blind, Multicenter, Phase 2 STRIVE Study

Á. Soriano, L. Ostrosky-Zeichner, P. Pappas, 2018, Open Forum Infectious Diseases.

Prototheca wickerhamii algaemia presenting as cholestatic hepatitis in a patient with systemic lupus erythematosus: A case report and literature review.

S. Moser, P. Pappas, Zaw Min, 2012, Medical mycology case reports.

Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology Clinic.

J. Perfect, S. Lockhart, A. Litvintseva, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non‐albicans Candida species

R. Betts, P. Pappas, O. Cornely, 2014, Mycoses.

Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi‐year, multicenter prospective cohort study

D. Paterson, E. Dubberke, R. Avery, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Reply to Herbrecht et al

J. Baddley, J. Donnelly, P. Pappas, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Relationship of T2 Candida Panel to Disease Severity, Mortality and Time to Therapy in Patients with Candidemia

P. Pappas, C. Hoesley, T. McCarty, 2017, Open Forum Infectious Diseases.

Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study

D. Paterson, E. Dubberke, R. Avery, 2017, Open forum infectious diseases.

Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris

Brendan R. Jackson, B. Jackson, S. Lockhart, 2017, Journal of Clinical Microbiology.

A Randomized, Double-Blind, Placebo-Controlled Trial of Systemically Administered Interferon-α, -β, or -γ in Combination with Cryotherapy for the Treatment of Condyloma Acuminatum

M. Stoler, L. Corey, L. Demeter, 1995 .

Safety and Tolerability of Voriconazole in Patients with Baseline Renal Insufficiency and Candidemia

J. Sobel, C. Viscoli, B. Kullberg, 2012, Antimicrobial Agents and Chemotherapy.

SYPHILIS 100 YEARS AGO: PARALLELS WITH THE AIDS PANDEMIC

P. Pappas, 1993, International journal of dermatology.

A randomized, double-blind trial of parenteral low dose versus high dose interferon-beta in combination with cryotherapy for treatment of condyloma acuminatum.

M. Stoler, L. Corey, R. Reichman, 1997, Antiviral research.

Human infection by genetically diverse SIVSM-related HIV-2 in West Africa

F. Gao, P. Sharp, G. Shaw, 1992, Nature.

COVID-19—Lessons Learned and Questions Remaining

R. Schooley, C. del Rio, Robin Patel, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients.

S. Chanock, T. Walsh, D. Ennis, 2007, Medical mycology.

Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group

L. Hutwagner, R. Pinner, E. Graviss, 1996, Journal of clinical microbiology.

Echinocandin resistance among Candida isolates at an academic medical centre 2005–15: analysis of trends and outcomes

S. Lockhart, S. Moser, C. Pham, 2018, The Journal of antimicrobial chemotherapy.

Association between Vancomycin-Resistant Enterococci Bacteremia and Ceftriaxone Usage

J. Baddley, L. Miller, S. Moser, 2012, Infection Control & Hospital Epidemiology.

Invasive Candidiasis.

P. Pappas, T. McCarty, 2016, Infectious disease clinics of North America.

Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections

J. Perfect, M. Weinstein, E. Mylonakis, 2019, Annals of Internal Medicine.

Impact of Infectious Disease Consultation on Clinical Management and Mortality in Patients With Candidemia.

J. M. Rodriguez, R. Griffin, P. Pappas, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reply to Tascini, et al.

J. M. Rodriguez, P. Pappas, B. Camins, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pulmonary infection due to Legionella cincinnatiensis in renal transplant recipients: two cases and implications for laboratory diagnosis.

K. Waites, E. Brookings, D. Jernigan, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibody and B Cell Subset Perturbations in Human Immunodeficiency Virus-Uninfected Patients With Cryptococcosis

L. Pirofski, A. Nakouzi, P. Pappas, 2017, Open forum infectious diseases.

Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).

J. Baddley, T. Zaoutis, L. Ostrosky-Zeichner, 2016, The Journal of antimicrobial chemotherapy.

Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients

S. Filler, A. Kendrick, W. Manosuthi, 2011, International journal of STD & AIDS.

Fungemia Caused by Zygoascus hellenicus in an Allogeneic Stem Cell Transplant Recipient

M. Brandt, B. Arthington-Skaggs, P. Pappas, 2004, Journal of Clinical Microbiology.

CASE REPORTS Fungemia Caused by Zygoascus hellenicus in an Allogeneic Stem Cell Transplant Recipient

M. Brandt, B. Arthington-Skaggs, P. Pappas, 2004 .

147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial

G. Rahav, R. Ferrer, B. Kullberg, 2020 .

Clinical Utility of Routine Use of Fungal Blood Cultures.

S. Leal, P. Pappas, P. Kulkarni, 2023, The American journal of medicine.

Target lesions in a neutropenic patient

P. Pappas, Zaw Min, 2014, Internal and Emergency Medicine.

Relapsing Fever Caused by Borrelia lonestari after Tick Bite in Alabama, USA

S. Leal, J. Lieberman, P. Pappas, 2023, Emerging infectious diseases.

1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI)

G. Lyon, B. Alexander, F. Marty, 2020 .

1157. Clinical Safety, Efficacy, and Pharmacokinetics of Fosmanogepix, a Novel First-in-class Antifungal, in Patients with Renal Insufficiency: Subset Analysis from a Phase 2 Candidemia Trial

G. Rahav, B. Kullberg, M. Hodges, 2020 .

Late-Onset Cerebral Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation

S. Mineishi, J. Curé, P. Pappas, 2017, The American journal of case reports.

144. MSG-15: Pharmacokinetic (PK), Adverse Events (AEs), and Tolerability Data from an Open Label Randomized Clinical Trial (RCT) Comparing Oral Suba-itraconazole (SUBA-ITC) to Conventional Itraconazole (C-ITC) for Treatment of Endemic Mycosis (EM)

P. Pappas, L. Proia, A. Spec, 2020, Open Forum Infectious Diseases.

Editorial commentary: An expanded role for therapeutic lumbar punctures in newly diagnosed AIDS-associated cryptococcal meningitis?

P. Pappas, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diagnosed AIDS-Associated Cryptococcal Meningitis?

P. Pappas, 2014 .

Invasive candidiasis

B. Kullberg, M. Arendrup, M. Lionakis, 2018, Nature Reviews Disease Primers.

Invasive Candidiasis.

P. Pappas, T. Mccarty, 2016, Infectious disease clinics of North America.

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.

J. Sobel, S. Filler, W. Manosuthi, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reply to Anaissie and Nucci and to Cisneros et al

J. Baddley, B. Kullberg, D. Andes, 2012 .

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

J. Sobel, S. Filler, J. Rex, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

K. Wannemuehler, B. Marston, Benjamin J Park, 2009, AIDS.

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

A. Shorr, P. Biswas, A. Reboli, 2011, BMC infectious diseases.

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

W. Powderly, J. Rex, J. Edwards, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

J. Baddley, S. Lockhart, J. Ito, 2011, Journal of Clinical Microbiology.

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

J. Perfect, S. Holland, J. Sobel, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phase I Evaluation of the Safety and Pharmacokinetics of Murine-Derived Anticryptococcal Antibody 18B7 in Subjects with Treated Cryptococcal Meningitis

A. Casadevall, J. Perfect, J. Aberg, 2005, Antimicrobial Agents and Chemotherapy.

Cryptococcosis in the developing world: an elephant in the parlor.

P. Pappas, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cryptococcal infections in non-HIV-infected patients.

P. Pappas, 2013, Transactions of the American Clinical and Climatological Association.

Ocular manifestations of candidemia.

J. Sobel, C. Viscoli, A. Rothova, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

J. S. Daly, A. Casadevall, I. Sia, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Evidence Supporting the Revised EORTC/MSGERC Definitions for Invasive Fungal Infections.

J. Donnelly, P. Pappas, S. Chen, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET).

G. Lyon, B. Alexander, J. Baddley, 2015, Medical mycology.

Reply to Luppi et al

L. Pagano, J. Wingard, J. Donnelly, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.